| 1 |
34348556 | Identifying requirements for RSK2 specific inhibitors. | 2021 Dec |
1 |
| 2 |
29615689 | Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity. | 2018 Apr 3 |
1 |
| 3 |
27528706 | Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer. | 2016 Nov |
1 |
| 4 |
25589938 | Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101. | 2015 Jan 8 |
1 |
| 5 |
22227582 | Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4. | 2012 Feb |
1 |
| 6 |
22846040 | Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor. | 2012 Aug 21 |
3 |
| 7 |
23519677 | Improving the affinity of SL0101 for RSK using structure-based design. | 2012 Feb 14 |
3 |
| 8 |
21619683 | Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein. | 2011 May 28 |
2 |
| 9 |
19036157 | Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. | 2008 |
1 |
| 10 |
16723511 | ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1. | 2006 Dec |
1 |